The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biologics Safety Testing Market Research Report 2025

Global Biologics Safety Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1714496

No of Pages : 83

Synopsis

The global Biologics Safety Testing market was valued at US$ 2467.4 million in 2023 and is anticipated to reach US$ 3976.4 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.

Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.

This report aims to provide a comprehensive presentation of the global market for Biologics Safety Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Safety Testing.

Report Scope

The Biologics Safety Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Safety Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologics Safety Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Lonza Group
  • Charles River
  • Merck
  • SGS
  • WuXi AppTec
  • Thermo Fisher Scientific
  • Sartorius
  • Cytovance Biologics
  • Pace Analytical Services
  • Toxikon

Segment by Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication and Characterization Tests
  • Bioburden Tests
  • Cell Line Authentication
  • Residual Host Contaminant Detection Tests
  • Adventitious Agent Detection Tests
  • Others

Segment by Application

  • Pharmaceutical
  • Medical Research

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Safety Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Safety Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Endotoxin Tests
1.2.3 Sterility Tests
1.2.4 Cell Line Authentication and Characterization Tests
1.2.5 Bioburden Tests
1.2.6 Cell Line Authentication
1.2.7 Residual Host Contaminant Detection Tests
1.2.8 Adventitious Agent Detection Tests
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologics Safety Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Medical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Safety Testing Market Perspective (2019-2030)
2.2 Biologics Safety Testing Growth Trends by Region
2.2.1 Global Biologics Safety Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Safety Testing Historic Market Size by Region (2019-2024)
2.2.3 Biologics Safety Testing Forecasted Market Size by Region (2025-2030)
2.3 Biologics Safety Testing Market Dynamics
2.3.1 Biologics Safety Testing Industry Trends
2.3.2 Biologics Safety Testing Market Drivers
2.3.3 Biologics Safety Testing Market Challenges
2.3.4 Biologics Safety Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Safety Testing Players by Revenue
3.1.1 Global Top Biologics Safety Testing Players by Revenue (2019-2024)
3.1.2 Global Biologics Safety Testing Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Safety Testing Revenue
3.4 Global Biologics Safety Testing Market Concentration Ratio
3.4.1 Global Biologics Safety Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Safety Testing Revenue in 2023
3.5 Biologics Safety Testing Key Players Head office and Area Served
3.6 Key Players Biologics Safety Testing Product Solution and Service
3.7 Date of Enter into Biologics Safety Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Safety Testing Breakdown Data by Type
4.1 Global Biologics Safety Testing Historic Market Size by Type (2019-2024)
4.2 Global Biologics Safety Testing Forecasted Market Size by Type (2025-2030)
5 Biologics Safety Testing Breakdown Data by Application
5.1 Global Biologics Safety Testing Historic Market Size by Application (2019-2024)
5.2 Global Biologics Safety Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Safety Testing Market Size (2019-2030)
6.2 North America Biologics Safety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Safety Testing Market Size by Country (2019-2024)
6.4 North America Biologics Safety Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Safety Testing Market Size (2019-2030)
7.2 Europe Biologics Safety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Safety Testing Market Size by Country (2019-2024)
7.4 Europe Biologics Safety Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Safety Testing Market Size (2019-2030)
8.2 Asia-Pacific Biologics Safety Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Safety Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Safety Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Safety Testing Market Size (2019-2030)
9.2 Latin America Biologics Safety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Safety Testing Market Size by Country (2019-2024)
9.4 Latin America Biologics Safety Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Safety Testing Market Size (2019-2030)
10.2 Middle East & Africa Biologics Safety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Safety Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Safety Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Detail
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biologics Safety Testing Introduction
11.1.4 Lonza Group Revenue in Biologics Safety Testing Business (2019-2024)
11.1.5 Lonza Group Recent Development
11.2 Charles River
11.2.1 Charles River Company Detail
11.2.2 Charles River Business Overview
11.2.3 Charles River Biologics Safety Testing Introduction
11.2.4 Charles River Revenue in Biologics Safety Testing Business (2019-2024)
11.2.5 Charles River Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Biologics Safety Testing Introduction
11.3.4 Merck Revenue in Biologics Safety Testing Business (2019-2024)
11.3.5 Merck Recent Development
11.4 SGS
11.4.1 SGS Company Detail
11.4.2 SGS Business Overview
11.4.3 SGS Biologics Safety Testing Introduction
11.4.4 SGS Revenue in Biologics Safety Testing Business (2019-2024)
11.4.5 SGS Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Detail
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Biologics Safety Testing Introduction
11.5.4 WuXi AppTec Revenue in Biologics Safety Testing Business (2019-2024)
11.5.5 WuXi AppTec Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Biologics Safety Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Biologics Safety Testing Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Detail
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Biologics Safety Testing Introduction
11.7.4 Sartorius Revenue in Biologics Safety Testing Business (2019-2024)
11.7.5 Sartorius Recent Development
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Detail
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Biologics Safety Testing Introduction
11.8.4 Cytovance Biologics Revenue in Biologics Safety Testing Business (2019-2024)
11.8.5 Cytovance Biologics Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Detail
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biologics Safety Testing Introduction
11.9.4 Pace Analytical Services Revenue in Biologics Safety Testing Business (2019-2024)
11.9.5 Pace Analytical Services Recent Development
11.10 Toxikon
11.10.1 Toxikon Company Detail
11.10.2 Toxikon Business Overview
11.10.3 Toxikon Biologics Safety Testing Introduction
11.10.4 Toxikon Revenue in Biologics Safety Testing Business (2019-2024)
11.10.5 Toxikon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’